Would Pfizer Inc. Buy King Pharmaceuticals®, Inc.? King Gains on Takeover Speculation

August 6, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Aug. 5 (Bloomberg) -- King Pharmaceuticals Inc.'s call- option trading was the busiest since 2004 and its shares rose to an 11-month high on speculation Pfizer Inc., the biggest U.S. drugmaker by market value, will buy the company.

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions

Pfizer